More efficient clinical trials through use of scientific model-based statistical tests.
about
Ozanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsiesModeling disease progression in acute stroke using clinical assessment scales.Comparisons of Analysis Methods for Proof-of-Concept Trials.Tips and traps analyzing pediatric PK data.Clinical trial simulation: a tool for understanding study failures and preventing them.Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and DocumentationReview: efficient rehabilitation trial designs using disease progress modeling: a pediatric traumatic brain injury example.Approaches to simultaneous analysis of frequency and severity of symptoms.Models for disease progression: new approaches and uses.Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resamplingThe use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example.Randomized exposure-controlled trials; impact of randomization and analysis strategies.Basic concepts in population modeling, simulation, and model-based drug development: part 3-introduction to pharmacodynamic modeling methodsDisease progression, drug action and Parkinson's disease: why time cannot be ignored.Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models.A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes.Optimizing disease progression study designs for drug effect discrimination.Interpreting the results of Parkinson's disease clinical trials: time for a change.
P2860
Q28543591-A866A6E4-9BCE-4370-BC1D-7827B5601D06Q30497328-9D1DA151-90DE-47E4-9CD8-5F2BAF4FF605Q30537763-CCB8DB26-82F5-4D3D-8AAF-31A6566DE1D9Q33820152-2DAE3FB8-1E9C-431B-85F7-60321F900FCCQ36055589-2A0246BB-CD64-40B7-BA61-F60A6DAB1D9EQ36734132-24CEB9EA-2310-4748-B5A0-DA277514C069Q37644175-F46B57F8-2834-4B10-B9AD-7FCE67ED1E74Q37770956-17161FAD-F1A1-40ED-A6BE-08334AA2FA14Q38012237-2B383447-8A29-4F5A-BC4F-F220CB0D03E8Q39064765-A1815444-8CE2-4580-8182-BF654500534AQ39300554-89DAFAF7-29D9-4BFB-86CB-9A4B1181A499Q41118521-1DB1E4AF-BB73-4409-BF42-B8513F2CD0AFQ41121488-425F4AA8-6703-426B-90CE-0E8B9A906F4BQ41775229-E9B86DF5-E56A-47E0-8DE0-CDC7468B3864Q42226525-60770BC7-70ED-4392-9A6D-B08D8450CD6BQ42546762-C79AB283-893D-4114-B9CE-6E2306F4AAA5Q43059458-6E844814-9C46-44A1-BB7F-166FE9C38DE8Q43837566-CD7D8026-E557-4A49-A6FA-E4538B6DD618Q45797972-BB9D104B-E0C3-405B-8F55-9F084E4C2E14
P2860
More efficient clinical trials through use of scientific model-based statistical tests.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
More efficient clinical trials through use of scientific model-based statistical tests.
@ast
More efficient clinical trials through use of scientific model-based statistical tests.
@en
type
label
More efficient clinical trials through use of scientific model-based statistical tests.
@ast
More efficient clinical trials through use of scientific model-based statistical tests.
@en
prefLabel
More efficient clinical trials through use of scientific model-based statistical tests.
@ast
More efficient clinical trials through use of scientific model-based statistical tests.
@en
P356
P1476
More efficient clinical trials through use of scientific model-based statistical tests.
@en
P2093
E Niclas Jonsson
Lewis B Sheiner
P304
P356
10.1067/MCP.2002.129307
P407
P577
2002-12-01T00:00:00Z